Afghanistan

Yellow Fever

  • Requirements: Required if traveling from a country with risk of YFV transmission. 1
  • Recommendations: None.

Malaria

  • Areas with malaria: April–December in all areas <2,500 m (8,202 ft).
  • Estimated relative risk of malaria for US travelers: Moderate. 3
  • Drug resistance 4: Chloroquine.
  • Malaria species: P. vivax 80%–90%, P. falciparum 10%–20%.
  • Recommended chemoprophylaxis: Atovaquone-proguanil, doxycycline, or mefloquine.

Citation

Brunette, Gary W., editor. "Afghanistan." CDC Yellow Book, Centers for Disease Control and Prevention, 2018. Relief Central, relief.unboundmedicine.com/relief/view/cdc-yellow-book/204201/all/Afghanistan.
Afghanistan. In: Brunette GW, ed. CDC Yellow Book. Centers for Disease Control and Prevention; 2018. https://relief.unboundmedicine.com/relief/view/cdc-yellow-book/204201/all/Afghanistan. Accessed March 25, 2019.
Afghanistan. (2018). In Brunette, G. W. (Ed.), CDC Yellow Book. Available from https://relief.unboundmedicine.com/relief/view/cdc-yellow-book/204201/all/Afghanistan
Afghanistan [Internet]. In: Brunette GW, editors. CDC Yellow Book. Centers for Disease Control and Prevention; 2018. [cited 2019 March 25]. Available from: https://relief.unboundmedicine.com/relief/view/cdc-yellow-book/204201/all/Afghanistan.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Afghanistan ID - 204201 ED - Brunette,Gary W, BT - CDC Yellow Book UR - https://relief.unboundmedicine.com/relief/view/cdc-yellow-book/204201/all/Afghanistan PB - Centers for Disease Control and Prevention DB - Relief Central DP - Unbound Medicine ER -